Cargando…

Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy

Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Seung Hyun, Lee, Chang-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Biotechnology and Bioengineering 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236339/
https://www.ncbi.nlm.nih.gov/pubmed/34220207
http://dx.doi.org/10.1007/s12257-020-0181-8
_version_ 1783714516091011072
author Kang, Seung Hyun
Lee, Chang-Han
author_facet Kang, Seung Hyun
Lee, Chang-Han
author_sort Kang, Seung Hyun
collection PubMed
description Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used, but recently, the engineered antibodies with various strategies according to the role of the therapeutic antibody have been used to maximize the therapeutic efficacy. In this review paper, first, the overall structural features and functional characteristics of antibody IgG, second, the old and new techniques for antibody discovery, and finally, several antibody engineering strategies for maximizing therapeutic efficacy according to the role of a therapeutic antibody will be introduced.
format Online
Article
Text
id pubmed-8236339
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Korean Society for Biotechnology and Bioengineering
record_format MEDLINE/PubMed
spelling pubmed-82363392021-06-28 Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy Kang, Seung Hyun Lee, Chang-Han Biotechnol Bioprocess Eng Invited Review Paper Monoclonal antibodies (mAb) have been used as therapeutic agents for various diseases, and immunoglobulin G (IgG) is mainly used among antibody isotypes due to its structural and functional properties. So far, regardless of the purpose of the therapeutic antibody, wildtype IgG has been mainly used, but recently, the engineered antibodies with various strategies according to the role of the therapeutic antibody have been used to maximize the therapeutic efficacy. In this review paper, first, the overall structural features and functional characteristics of antibody IgG, second, the old and new techniques for antibody discovery, and finally, several antibody engineering strategies for maximizing therapeutic efficacy according to the role of a therapeutic antibody will be introduced. The Korean Society for Biotechnology and Bioengineering 2021-06-28 2021 /pmc/articles/PMC8236339/ /pubmed/34220207 http://dx.doi.org/10.1007/s12257-020-0181-8 Text en © The Korean Society for Biotechnology and Bioengineering and Springer 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Invited Review Paper
Kang, Seung Hyun
Lee, Chang-Han
Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
title Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
title_full Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
title_fullStr Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
title_full_unstemmed Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
title_short Development of Therapeutic Antibodies and Modulating the Characteristics of Therapeutic Antibodies to Maximize the Therapeutic Efficacy
title_sort development of therapeutic antibodies and modulating the characteristics of therapeutic antibodies to maximize the therapeutic efficacy
topic Invited Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236339/
https://www.ncbi.nlm.nih.gov/pubmed/34220207
http://dx.doi.org/10.1007/s12257-020-0181-8
work_keys_str_mv AT kangseunghyun developmentoftherapeuticantibodiesandmodulatingthecharacteristicsoftherapeuticantibodiestomaximizethetherapeuticefficacy
AT leechanghan developmentoftherapeuticantibodiesandmodulatingthecharacteristicsoftherapeuticantibodiestomaximizethetherapeuticefficacy